罗欣药业：拟6756万元受让罗欣健康科技19.0526%股权，实现全资控股

Core Viewpoint - Recently, Luoxin Pharmaceutical (002793) announced plans to acquire a 19.0526% stake in Luoxin Health Technology (Beijing) Co., Ltd. from Chengdu Deyixinhua Equity Investment Partnership (Limited Partnership) for 67.56 million yuan, increasing its ownership from 80.9474% to 100% [1] Group 1 - The transaction is valued at 67.56 million yuan, corresponding to Chengdu Deyixin's paid-in capital of 67.37 million yuan [1] - The completion of this transaction will result in Luoxin Pharmaceutical holding a full 100% stake in Luoxin Health Technology [1] - This transaction is classified as a related party transaction, as Chengdu Deyixin and its concerted parties hold more than 5% of Luoxin Pharmaceutical's shares [1]